Your browser doesn't support javascript.
loading
Blinatumomab plus hyper-CVAD: the prelude to a new era in acute lymphocytic leukaemia.
León, Andrés Gómez-De; Mejía-Aranguré, Juan Manuel.
Affiliation
  • León AG; Facultad de Medicina y Hospital Universitario Dr José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
  • Mejía-Aranguré JM; Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico; Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico. Electronic address: jmejia@inmegen.gob.mx.
Lancet Haematol ; 9(12): e864-e865, 2022 12.
Article in En | MEDLINE | ID: mdl-36279878
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Humans Language: En Journal: Lancet Haematol Year: 2022 Document type: Article Affiliation country: Mexico Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Humans Language: En Journal: Lancet Haematol Year: 2022 Document type: Article Affiliation country: Mexico Country of publication: United kingdom